The Jackson Heart Study (JHS) assesses cardiovascular disease risk factors among African Americans in Jackson, Mississippi. Whether characteristics of JHS participants differ from those of a broader African American population are unknown.
unknown. We compared Medicare beneficiaries in the JHS to regional and national cohorts of African American beneficiaries to establish a context for interpreting analyses of the JHS. The overall goal was to obtain deeper insight into the applicability of cardiovascular biomarkers, risk factors, and outcomes observed in the JHS for other African American populations. In addition to comparing demographic characteristics, comorbid conditions, and resource use among the groups, we investigated differences in their overall survival over 10 years.
METHODS

Data Sources
The JHS is a prospective, community-based, observational study designed to assess determinants of cardiovascular disease in an African American population. 5 It was set up as an outgrowth of the ARIC study, of which Jackson, Mississippi, was one of four sites, to secure new and already participating African Americans. 6 Data collection began in 2000, and recruitment methods have been described in detail. 7 In brief, subjects recruited from four subsamples of participants were included: random (921/5,302 [17. We obtained inpatient, skilled nursing facility, hospice, home health, outpatient facility, carrier, and durable medical equipment claim files and the corresponding denominator files for 2002 through 2012 from the US Centers for Medicare and Medicaid Services (CMS) for all Medicare-eligible JHS cohort participants. In addition, we obtained standard analytic claim files and corresponding denominator files for 2002 through 2012 from CMS for a nationally representative 5% sample of Medicare beneficiaries. The inpatient files include institutional claims for facility costs covered under Medicare part A. The outpatient files include claims from outpatient institutional providers, and the carrier files include noninstitutional provider claims for services covered under Medicare part B. The denominator files include beneficiary demographic characteristics, dates of death, and program eligibility and enrollment information. Only claims filed during periods of fee-for-service coverage were included. The institutional review board of the Duke University Health System approved the study.
Study Population
We created three cohorts of African American Medicare beneficiaries who were 65 years old or older and were enrolled in fee-for-service Medicare for 1 year preceding 1 January 2003: the JHS-Medicare cohort, a Medicare regional cohort (i.e., a Medicare 5% sample from the South census region), and a Medicare national cohort (i.e., the full Medicare 5% sample).
The South census region includes Alabama, Arkansas, Delaware, the District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. 
Outcomes
We assessed outcomes for beneficiaries in each of the three cohorts from 1 January 2003 (cohort entry date) through 31 December 2012. The primary outcomes of interest were cumulative incidence of all-cause mortality and the following metrics of Medicare resource use: cumulative incidence of all-cause hospitalization, cumulative incidence of outpatient emergency department encounters, mean number of outpatient evaluation and management visits in 2003, and mean total Medicare costs in 2003.
All-cause mortality was based on death dates in the Medicare denominator file. All-cause hospitalizations were ascertained from inpatient claim files, excluding transfers to another hospital and admissions for rehabilitation ( 
Covariates
Baseline age, sex, and indication for Medicare insurance coverage (i.e., disability insurance benefit, diagnosis of end-stage renal disease, or both, and dual Medicare-Medicaid eligibility) were ascertained from the denominator file. We derived a rural indicator variable from rural-urban commuting area scores based on the zip code of residence. 8 We identified comorbid conditions using previously validated coding algorithms 9, 10 and searched all inpatient, outpatient, and carrier claims in 2002 for evidence of cancer, cerebrovascular diseases, chronic obstructive pulmonary disease, dementia, diabetes mellitus, heart failure, hypertension, ischemic heart disease, myocardial infarction, peptic ulcer, peripheral vascular disease, renal disease, stroke or transient ischemic attack, and valvular disease (eTable 1; http://links.lww.com/EDE/B214).
Statistical Analysis
For baseline characteristics of the study population, we present categorical variables as frequencies with percentages and continuous variables as means with standard deviations (SDs) stratified by cohort. We tested for differences between cohorts using χ 2 tests for categorical variables and Wilcoxon rank-sum tests for continuous variables. We tested for pairwise differences between (1) the JHS-Medicare cohort and the regional cohort and (2) the JHS-Medicare cohort and the national cohort. For all analyses, we weighted beneficiaries in the regional and national cohorts such that each cohort reflected the age and sex distributions of the JHS-Medicare cohort. For weighting, we truncated age at 94 years for all cohorts, which is the maximum age in the JHS cohort. Of 60 possible age-sex groups, 48 were represented in the JHS cohort. Beneficiaries in the regional and national cohorts in unrepresented groups were assigned a weight of zero.
We calculated age-and sex-adjusted Kaplan-Meier estimates of 10-year mortality, hospitalization outcomes (i.e., all-cause, cardiovascular, cerebrovascular, and heart failure hospitalizations), and outpatient emergency department encounters and log-rank tests to assess pairwise differences in outcomes by cohort (i.e., JHS-Medicare cohort vs. regional cohort; JHS-Medicare cohort vs. national cohort). The censoring date was the earliest of (1) the end of the 10-year follow-up period; (2) the date on which the patient's data were no longer available because the patient enrolled in a Medicare managed care plan; (3) for outcomes other than mortality, the date of death; or (4) 31 December 2012. We used Cox proportional hazard models to compare unadjusted and multivariable-adjusted mortality, hospitalizations, and outpatient emergency department encounters by cohort (separate models for JHS-Medicare cohort vs. regional cohort, and JHS-Medicare cohort vs. national cohort). The multivariableadjusted models controlled for age, sex, Medicaid eligibility, rural location, and baseline comorbid conditions.
We describe counts of outpatient evaluation and management visits and total Medicare costs in 2003 by cohort using means with SDs, and we tested for differences using Wilcoxon rank-sum tests. All costs are reported as observed 2003 US dollars. The analyses of evaluation and management visits and costs were restricted to beneficiaries who were continuously enrolled in fee-for-service Medicare from 1 January 2003 through 31 December 2003, or until the date of death if it occurred in 2003.
We conducted three sensitivity analyses. First, we accounted for possible overlap between the JHS-Medicare and Medicare cohorts (approximately 60 beneficiaries). Because beneficiary encryption for the JHS-Medicare cohort differed from the Medicare 5% sample, we removed beneficiaries who resided in the JHS counties (i.e., Madison, Hinds, and Rankin) from the regional and national cohorts and repeated outcomes analyses. Second, we assessed outcomes in the subgroup of JHS participants who had continuous fee-for-service Medicare until death or end of study, excluding those who switched to managed care. Finally, we conducted a subgroup analysis of beneficiaries who were dually eligible for Medicare and Medicaid, given the significant baseline differences of its frequency between the JHS and Medicare cohorts.
Statistical significance was established with two-tailed α = 0.05 for all tests. We used SAS version 9.4 (SAS Institute Inc., Cary, NC) for all analyses.
RESULTS
Overall, 1105/5302 (21%) participants in the JHS were included in the JHS-Medicare cohort. We studied three cohorts over a 10-year follow-up period: the JHS-Medicare cohort (n = 1,105), the Medicare regional cohort (n = 57,489), and the Medicare national cohort (n = 95,494). Table 1 shows the baseline characteristics of each cohort. Compared with the regional and national cohorts, the JHS-Medicare cohort was younger, included more women, and had fewer beneficiaries who were dually eligible for Medicare and Medicaid. After adjustment for age and sex, beneficiaries in the JHS-Medicare cohort were less likely to have a history of heart failure, ischemic heart disease, diabetes mellitus, cerebrovascular disease, chronic obstructive pulmonary disease, and renal disease. Over the study duration, 59% (654/1,105) of beneficiaries in the JHS-Medicare cohort switched to a managed care plan (vs. 28% and 29% in regional cohorts, respectively). These beneficiaries were more likely to be women (80% vs. 63%), to be dually eligible for Medicare and Medicaid (28% vs. 20%), and to have diabetes (32% vs. 26%). Other demographic characteristics and rates of comorbid conditions were similar.
The age-and sex-adjusted cumulative incidence of allcause mortality was lower in the JHS-Medicare cohort (29%; 95% confidence interval [CI] = 25, 33), compared with both the regional cohort (43%; 95% CI = 42, 44) and the national cohort (43%; 95% CI = 42, 43; Figure 1 and eTable 2; http://links. lww.com/EDE/B214). The greater mortality risk in the Medicare cohorts remained after adjustment in the full multivariable model (hazard ratio [HR] for the regional cohort = 1.52; 95% CI = 1.31, 1.76; HR for the national cohort = 1.49; 95% CI = 1.29, 1.73; Table 2 ). In addition, the JHS-Medicare cohort had lower age-and sex-adjusted cumulative incidence of allcause hospitalization (71%; 95% CI = 68, 75), compared with the regional cohort (79%; 95% CI = 78, 79) and the national cohort (79%; 95% CI = 78-79; Figure 2 and eTable2; http:// links.lww.com/EDE/B214) and a lower cumulative incidence of outpatient emergency department encounters (78%; 95% CI = 74, 81), compared with the regional cohort (83%; 95% CI = 83, 84) and the national cohort (82%; 95% CI = 82, 82); eFigure; http://links.lww.com/EDE/B214 and eTable2; http://links.lww. com/EDE/B214). However, the risks for both outcomes were similar after multivariable adjustment. (Table 3) .
We conducted three sensitivity analyses. When we excluded JHS counties from the regional and national cohorts, the risks of mortality, hospitalization, and emergency department encounters remained higher in the Medicare cohorts than in the JHS-Medicare cohort (eTable 3; http://links.lww. com/EDE/B214). Second, we assessed only beneficiaries who had continuous fee-for-service Medicare until death or end of study (eTable 4; http://links.lww.com/EDE/B214). Although the directions of associations were similar, the adjusted hazard for mortality was attenuated compared with the primary cohort analyses. In contrast, the adjusted hazards for all-cause hospitalization and outpatient emergency department encounters were strengthened compared with the primary analysis. Last, we studied only participants with dual Medicare-Medicaid eligibility. Dually eligible participants in the JHS-Medicare cohort compared with those in the regional and national cohorts remained younger, were more likely to be women, and were less likely to have history of cerebrovascular disease and chronic obstructive pulmonary disease, but they had similar age-and sex-adjusted rates of heart failure, diabetes mellitus, ischemic heart disease, and renal disease (eTable 5; http:// Beneficiaries in the Medicare regional and national cohorts were weighted to the age and sex distribution of the JHS-Medicare cohort. For weighting, we truncated age at 94 years for all cohorts, which is the maximum age in the JHS cohort. Of 60 possible age-sex groups, 48 were represented in the JHS cohort. Regional and national Medicare beneficiaries in unrepresented groups were assigned a weight of zero.
IQR indicates interquartile range.
FIGURE 1.
Age-and sex-adjusted cumulative incidence of allcause mortality by cohort.
links.lww.com/EDE/B214). Dually eligible beneficiaries in the regional and national cohorts again had greater mortality risk before and after multivariable adjustment, but the strength of these associations was attenuated relative to the primary analyses ( Table 4 ). The comparison of hospitalization and emergency department encounter risks were both nonsignificant after adjustment.
DISCUSSION
In this analysis of the representativeness of JHS participants for a broader African American population, we found several important differences between the JHS-Medicare cohort and the regional and national cohorts. JHS participants were younger, had fewer comorbid conditions, and were less likely to be dually eligible for Medicare and Medicaid, a marker of low socioeconomic status compared with both the South census region and national cohorts. Consistent with these findings, age-and sex-adjusted Kaplan-Meier analyses showed that the regional and national cohorts had virtually identical survival curves over 10 years of follow-up, whereas the JHSMedicare cohort fared substantially better, even after covariate adjustment. Analysis of health care resource use consistently showed that the JHS-Medicare cohort also had less interaction with health care providers during the study period.
Placing the JHS cohort within the spectrum of a defined population, and understanding its relative trajectory over time, offers perspective for findings from JHS analyses. 1 Previous assessments of the external validity of other population-based cohorts, including the Framingham Heart Study and the Cardiovascular Health Study, provided a similar framework.
2,11,12
Although we found no evidence to discount the prognostic relevance of cardiovascular risk factors in the JHS population, our results suggest that the distribution and prevalence of risk factors and interactions with the local health care system should be considered in assessments of absolute health risks for a specific African American population. We note several potential factors contributing to the unique attributes of the JHS population, including the recruitment strategy of the cohort, volunteer bias, and the influence of socioeconomic status.
Approximately 22% of JHS participants were recruited as part of the ARIC study in an effort to address underrepresentation of African American participants in cardiovascular disease research and to create the largest historical study of African American patients from a single site. 7 There was a deliberate effort to include participants representing all levels of socioeconomic status, and overall participation rates in JHS exams 2 and 3 were 77% to 81%, respectively. However, recruitment was challenging; compared with other ARIC study sites, 20% fewer Jackson residents remained in the JHS after the initial home interview. 13 Similar to Framingham's methods, the JHS random sample was also enriched with volunteers meeting inclusion criteria (30%) to compensate for high costs and low response from random sampling. Therefore, volunteer bias, a common potential limitation of population-based cohort studies, 2 may have skewed the study population. Compared with 2000 US Census data for the Jackson metropolitan statistical area, the overall JHS cohort at the time of recruitment in 2000 was more likely to have at least a high school education (77.7% vs. 70.5%) and self-reported income of $50,000 or greater (34.1% vs. 22.1%). 7 However, among ARIC sites, socioeconomic status and comorbid conditions among nonrespondents differed from those of survey The Jackson Heart Study-Medicare cohort served as the reference group. b Adjusted for age, sex, Medicaid eligibility, urban location, and baseline comorbid conditions: cancer, cerebrovascular disease, chronic obstructive pulmonary disease, congestive heart failure, dementia, diabetes, hypertension, ischemic heart disease, myocardial infarction, peripheral vascular disease, renal disease, valvular heart disease, and peptic ulcer disease. Proportionality assumptions were met for study variable (regional/national) in all models.
respondents to a lesser extent among African American participants than among white participants. 13 Perhaps partly explained by volunteer bias and cohort enrichment, we observed lower rates of Medicaid eligibility in the JHS-Medicare cohort and, therefore, performed a sensitivity analysis for dually eligible participants. Dually eligible beneficiaries have high rates of cognitive impairment, multiple chronic conditions, greater medical needs, and more complex care, combined with low income, worse survival, and more hospitalizations. [14] [15] [16] [17] As expected, the JHS-Medicare subgroup with dual eligibility had a greater disease burden and worse outcomes, compared with those without dual eligibility. Their overall profiles were more similar to corresponding Medicare 5% sample subgroups than overall cohort comparisons, and between-group differences in outcomes and health care resource use were attenuated. It is possible that further adjustment for socioeconomic status with additional variables such as income and education may account for remaining differences.
Our analysis of the JHS-Medicare cohort highlights the importance of recognizing the context and potential limitations of population-based cohort studies, which continue to aid in making new scientific discoveries and generating new, testable hypotheses for diverse populations. 18 Precisely defining the population the cohort represents (or does not represent) may reveal unexpected results and will become more important as observational epidemiologic research continues to evolve and the value of combining data sets appreciates. Whether due to differences in ethnicity, geographic location, sampling strategy, or other reasons specific to the cohort, these characteristics must be considered when investigating population-based cohort studies.
Observed differences in phenotype and outcome in the JHS-Medicare cohort may reflect healthy volunteer bias and higher socioeconomic status. Although absolute rates of disease and outcomes may not be representative of the larger group and, therefore, should not be used as surrogate values based on our findings, the JHS-Medicare cohort may still provide useful insight into the relative trajectory of disease in African American patients and their health.
This was a retrospective analysis from an observational cohort study. A sizeable portion of the JHS-Medicare cohort switched their original fee-for-service Medicare plan to managed care, and their claims data for hospitalizations and resource use were censored at the time of the switch. The participants who switched had lower socioeconomic status and comorbid diabetes but overall similar comorbid conditions at baseline. Although we adjusted for covariates, our analysis was limited to data found in Medicare claims and denominator files. Other measured and unmeasured factors including income, education, disease severity, and access to care may have influenced our findings.
Our primary finding, that the JHS cohort differs in profile, resource use, and outcomes from other groups of African American Medicare beneficiaries after adjustment, implies that absolute rates of disease and resource use observed in the JHS may not generalize to broader groups of African Americans. Instead, the data set should be used for understanding disease trajectories and risk factor associations. As researchers move to understand how to best use data from large The Jackson Heart Study-Medicare cohort served as the reference group. b Adjusted for age, sex, urban location, and baseline comorbid conditions: cancer, cerebrovascular disease, chronic obstructive pulmonary disease, dementia, diabetes, heart failure, hypertension, ischemic heart disease, myocardial infarction, peptic ulcer disease, peripheral vascular disease, renal disease, and valvular heart disease. Proportionality assumptions were met for study variable (regional/national) in all models.
groups of people, we believe this study serves as an important reminder of the strengths and limitations of the communitybased cohort study design.
CONCLUSIONS
Older participants in the JHS population have fewer health problems, lower health care resource use, and better survival compared with regional and national cohorts of Medicare beneficiaries. These differences were partially explained by differences in socioeconomic status.
